CClinicalTrials.gg
Status unknownNCT00910169EVHANUpdated Aug 7, 2012

Evaluation of Hospitalization for Anorexia Nervosa (EVALuation de l'Apport de l'HOSPITalisation Pour Anorexie Mentale : EVALHOSPITAM)

An observational study in Anorexia Nervosa, sponsored by Institut Mutualiste Montsouris. Status unknown at 1 site in France. Open to participants aged 8 Years to 65 Years. Per ClinicalTrials.gov, last updated 2012-08-07.

Sponsored by Institut Mutualiste Montsouris · Observational

The sponsor has not verified this record recently (last verified May 2009), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
8 Years to 65 Years
Sex
All
01

Study summary

The objective of this research is to evaluate the efficacy of five different in-patient treatment modalities and predictive factors of outcome for anorexia nervosa. The primary hypothesis is that the different treatment types impact outcome of patients at discharge from inpatient treatment and at one year follow-up, even after adjustment for confounding factors (age, length of illness, number of previous hospitalizations, clinical state at intake).

Read the detailed description

This study will evaluate global, psychiatric, somatic and psychosocial outcome for inpatients with anorexia nervosa through three evaluations (intake, discharge and one-year follow-up). The study will also consider five types of in-patient treatment in a naturalistic setting (i.e., patients will not be assigned to different treatment conditions; rather, we will study inpatient care as it exists today). The five treatment modalities to be studied are:

  1. Discharge weight objectives.
  2. The practice of a separation period.
  3. The use of clear nutritional and dietary objectives (cognitive/behavioural).
  4. The intensity of family involvement in treatment.
  5. Stabilisation phase before ending inpatient treatment.
02

Conditions studied

  • Anorexia Nervosa

Keywords

  • Anorexia nervosa
  • treatment
  • inpatient
  • efficacy
  • outcome
03

In context

Anorexia

411 studies on the registry are indexed under Anorexia; 67 are open to participants now.

This study's planned enrollment of 300 is above the median of 65 across 104 observational studies indexed under Anorexia.

Browse Anorexia studies →

Lead sponsor

Institut Mutualiste Montsouris is the lead sponsor of 35 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients hospitalisied in 11 tertiary centers for eating disorders in france

Inclusion criteria

  • All patients who accept participation between 8 and 50 years old, consecutively hospitalized for a DSM IV diagnosis of Anorexia Nervosa in one of the departments participating in this research by necessity of physical condition (BMI \< 15, rapid weight loss) or psychological condition
  • Parents of participating patients still living with their parents who accept participation

Exclusion criteria

Exclusion Criteria:

  • Refusal of research
  • Patients who do not speak French
  • Patients with a related somatic illness (diabetes, Crohn's disease, metabolic illness)
  • Patients not covered by social security health insurance
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Biospecimen retention
Samples without dna

Groups and cohorts

  • inpatient treatment

    naturalistic treatment no modification: observational study

    Other: inpatient treatment

Interventions

  • Otherinpatient treatment

    Hospitalisation modalities are described but are naturalistic

    Also known as: naturalistic treatment

06

What researchers measure

Primary outcomes

  1. Morgan and Russell score

    Time frame: one year follow-up

Secondary outcomes

  1. Nutritional status

    Time frame: one year follow-up

  2. Eating disorders symptoms and diagnosis

    Time frame: one year follow-up

  3. Psychiatric symptoms and disorders

    Time frame: one year follow-up

  4. Cognitive functioning

    Time frame: one year follow-up

  5. Somatic symptoms and complications

    Time frame: one year follow-up

  6. Social adjustment

    Time frame: one year follow-up

  7. Quality of life

    Time frame: one year follow-up

  8. Family relationships

    Time frame: one year follow-up

  9. Re-hospitalization

    Time frame: one year follow-up

07

Study locations

1 site
  • Insitut Mutualiste Montsouris
    Paris, 75014, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00910169
Lead sponsor
Institut Mutualiste Montsouris
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France, Ministry of Health, France, National Research Agency, France, National Health Insurance Fund, Fondation de la Mutuelle Générale de l'Education Nationale, Fondation de France
First posted
May 29, 2009
Start date
Mar 2009
Primary completion
Oct 2012 (estimated)
Completion
Oct 2012 (estimated)
Last update
Aug 7, 2012

Study contacts

Godart Nathalie, PhD
principal investigator · INSERM and Institut Mutualiste Montsouris

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion